UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): April 29, 2016


Commission File No. 001-12575


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)

UTAH
87‑0342734
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)

7043 South 300 West
Midvale, Utah  84047
Address of principal executive offices


Registrant's telephone number:
(801) 566‑1200

ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On April 29, 2016 at the annual meeting, shareholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:

Elected Barbara A. Payne as a director of the Company:
       
 
For
1,783,768
Withheld
1,229,992
Broker Non Votes
440,435
  
 
Ratified the selection of Jones, Simkins P.C. as the Company's independent public accounting firm for the year ended December 31, 2016:
      
 
For
3,385,304
Against
56,151
Abstentions
12,740
  
Approved, on an advisory basis, the compensation paid to UTMD's named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:
       
 
For
2,981,201
Against
25,510
Abstentions
7,049
Broker Non Votes                             440,435

 
SIGNATURES


Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
   
Date: 5/02/2016
 By:  /s/ Kevin L. Cornwell
 
Kevin L. Cornwell
 
CEO